Novel personalized treatment approach targets folate receptors on cancer cells…
Mixed results for Novartis' novel heart drug…
BioNano Genomics today released its breakthrough Irys System an intuitively designed genome mapping system that empowers genomics researchers with a new way of achieving more accurat…
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate (TAF; formerly referred to as GS-7340…
